Pediatrix Medical Group (MD) Competitors $12.76 -0.12 (-0.91%) Closing price 03:59 PM EasternExtended Trading$12.74 -0.03 (-0.22%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MD vs. AMED, AMN, CCRN, DGX, LH, DVA, CHE, CRVL, SEM, and EHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Quest Diagnostics (DGX), Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Select Medical (SEM), and Encompass Health (EHC). Pediatrix Medical Group vs. Amedisys AMN Healthcare Services Cross Country Healthcare Quest Diagnostics Laboratory Co. of America DaVita Chemed CorVel Select Medical Encompass Health Amedisys (NASDAQ:AMED) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment, dividends and community ranking. Which has better earnings and valuation, AMED or MD? Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedisys$2.37B1.31-$9.75M$2.7135.02Pediatrix Medical Group$2.01B0.55-$60.41M-$1.20-10.77 Do analysts recommend AMED or MD? Amedisys presently has a consensus target price of $100.75, indicating a potential upside of 6.16%. Pediatrix Medical Group has a consensus target price of $16.75, indicating a potential upside of 29.64%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedisys 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more risk & volatility, AMED or MD? Amedisys has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Is AMED or MD more profitable? Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -4.92%. Pediatrix Medical Group's return on equity of 15.47% beat Amedisys' return on equity.Company Net Margins Return on Equity Return on Assets Amedisys3.57% 12.20% 6.74% Pediatrix Medical Group -4.92%15.47%5.64% Do institutionals & insiders have more ownership in AMED or MD? 94.4% of Amedisys shares are owned by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are owned by institutional investors. 2.1% of Amedisys shares are owned by insiders. Comparatively, 0.9% of Pediatrix Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media favor AMED or MD? In the previous week, Amedisys had 23 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 28 mentions for Amedisys and 5 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.33 beat Amedisys' score of 1.04 indicating that Pediatrix Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amedisys 15 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pediatrix Medical Group 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer AMED or MD? Pediatrix Medical Group received 11 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.14% of users gave Pediatrix Medical Group an outperform vote while only 58.63% of users gave Amedisys an outperform vote. CompanyUnderperformOutperformAmedisysOutperform Votes49658.63% Underperform Votes35041.37% Pediatrix Medical GroupOutperform Votes50760.14% Underperform Votes33639.86% SummaryAmedisys and Pediatrix Medical Group tied by winning 9 of the 18 factors compared between the two stocks. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupHospitals IndustryMedical SectorNYSE ExchangeMarket Cap$1.11B$5.09B$5.56B$18.97BDividend YieldN/A0.99%5.11%4.02%P/E Ratio-10.7712.4422.4832.71Price / Sales0.551.05394.5627.84Price / Cash4.917.7938.1817.53Price / Book1.452.406.774.47Net Income-$60.41M$212.93M$3.22B$1.02B7 Day Performance3.36%9.69%1.48%0.50%1 Month Performance-10.92%5.10%3.99%-2.83%1 Year Performance43.40%16.69%16.15%4.36% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group2.0401 of 5 stars$12.76-0.9%$16.75+31.2%+45.7%$1.10B$2.01B-10.647,850Upcoming EarningsPositive NewsAMEDAmedisys2.9024 of 5 stars$94.69+0.2%$100.75+6.4%+3.1%$3.11B$2.37B37.5820,000Analyst RevisionAMNAMN Healthcare Services4.2448 of 5 stars$19.33+0.7%$38.67+100.0%-65.9%$738.19M$2.98B-5.024,230Upcoming EarningsAnalyst RevisionNews CoverageCCRNCross Country Healthcare3.5199 of 5 stars$13.51-1.7%$18.41+36.2%-23.0%$442.94M$1.34B-270.152,700Upcoming EarningsAnalyst ForecastNews CoverageDGXQuest Diagnostics4.569 of 5 stars$176.64+1.7%$185.07+4.8%+29.1%$19.72B$10.16B22.9749,000Analyst ForecastShort Interest ↑LHLaboratory Co. of America4.7227 of 5 stars$230.45+0.9%$268.77+16.6%+19.6%$19.28B$13.01B26.1375,500Earnings ReportAnalyst ForecastShort Interest ↑DVADaVita4.2802 of 5 stars$140.64+0.8%$166.33+18.3%+1.9%$11.25B$12.82B13.0970,000Positive NewsCHEChemed4.5788 of 5 stars$565.32+1.7%$674.00+19.2%+2.0%$8.26B$2.49B28.5714,200Analyst ForecastPositive NewsCRVLCorVel0.9411 of 5 stars$109.75-0.5%N/A+36.6%$5.64B$871.31M64.564,230News CoveragePositive NewsSEMSelect Medical4.9879 of 5 stars$18.16+4.7%$26.80+47.6%-35.6%$2.34B$5.19B11.0153,800Insider TradeNews CoverageHigh Trading VolumeEHCEncompass Health4.4795 of 5 stars$115.35+1.7%$120.86+4.8%+40.4%$11.62B$5.37B25.8635,000Earnings ReportDividend AnnouncementAnalyst ForecastInsider TradeAnalyst RevisionNews CoveragePositive News Related Companies and Tools Related Companies AMED Competitors AMN Competitors CCRN Competitors DGX Competitors LH Competitors DVA Competitors CHE Competitors CRVL Competitors SEM Competitors EHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.